1.     Amin A, Jhaveri M and Lin J. Cost Burden to US Payers of ATHENA-Like Patients With Atrial Fibrillation/Atrial Flutter. Heart Rhythm Society (HRS) Conference, 2011.

2.     Deitelzweig S, Thompson S, Lin J, McMorrow D and Johnson BH. Impact of CMS VTE Hospital Acquired Conditions (HAC) Policy on Hospital Cost and Revenue associated with Major Surgical Hip and Knee Procedures. 2011, Annual Meeting of Society of Hospital Medicine (SHM).

3.     Amin A, Deitelzweig S, Lin J, Belk K, Baumer D. Impact of Hyponatremia on Patient Outcomes and Health-Care Resource Utilization in Hospitalized Patients. 2011, Annual Meeting of Society of Hospital Medicine (SHM).

4.     Deitelzweig S, Amin A, Lin J, Baumer D, Belk K. Impact of hyponatremia on the readmission rates of hospitalized patients. 2011, Annual Meeting of Society of Hospital Medicine (SHM).

5.     Amin A, Varker H, Princic N, Lin J, Thompson S and Johnston S.  Duration of risk of venous thromboembolism in patients hospitalized for medical illnesses in the USA. 2011, Annual Meeting of Society of Hospital Medicine (SHM).

6.     Kim MH, Smith PJ, Jhaveri M, Lin J, Klingman D. Amiodarone and Sotalol in Atrial Fibrillation: Treatment Persistence and Occurrence of Adverse Events in the Real-World Setting 2011 American College of Cardiology (ACC).

7.     Alpert JS, Guerin A, Lin J, Jhaveri M and Wu EQ. Evaluation of International Normalized Ratio Monitoring and Anticoagulation Control in Atrial Fibrillation/Flutter Patients Using Warfarin and Antiarrhythmic Drug Therapy. 2011 American College of Cardiology (ACC).

8.     Guerin A, Lin J, Jhaveri M, Wu E and Alpert J. Real-World Clinical Outcomes and Costs in Atrial Fibrillation/Flutter Patients on Combined Warfarin and Antiarrhythmic Drug Therapy. American Managed Care Pharmacy (AMCP) Annual Conference, 2011.

9.     Amin A, Princic N, Lin J, Thompson S and Johnston S. Real-World Analysis of the Duration of Risk of Venous Thromboembolism In US Surgical Patients. 2010 Annual Meeting of the American Society of Hematology (ASH). Podium Presentation.

10.  Amin A, Lin J and Wiederkehr D. Real-World Analysis of Venous Thromboembolism Rates and Thromboprophylaxis Prescribing In US Patients with Cancer. 2010 Annual Meeting of the American Society of Hematology (ASH).

11.  Deitelzweig S, Thompson S, Lin J, McMorrow D and Johnson BH. Impact of CMS VTE Hospital Acquired Conditions (HAC) Policy on Hospital Cost and Revenue associated with Major Surgical Hip and Knee Procedures. 2010 Annual Meeting of the American Society of Hematology (ASH).

12.  Naccarelli GV, Johnston SS, Dalal M, Lin J and Patel PP. High Cost Burden of Atrial Fibrillation/Atrial Flutter in Older Patients (≥65 years) in the United States. American Heart Association Scientific Sessions (AHA) 2010.

13.  Amin A, Lin J and Wiederkehr D. Real-world Analysis of Deep Vein Thrombosis Prevention in Patients with Severe Lung Disease. American College of Chest Physicians (ACCP)-CHEST 2010.

14.  Amin A, Lin J and Wiederkehr D. Readmission for Venous Thromboembolism in US Patients Following Hospitalization for Major Orthopedic Surgery. American College of Surgeons (ACS) 2010 Clinical Congress. Podium Presentation.

15.  Amin A, Lin J and Wiederkehr D. Inpatient and Outpatient Rates of Venous Thromboembolism and Thromboprophylaxis in US Patients following Major Abdominal Surgery. American College of Surgeons (ACS) 2010 Clinical Congress.

16.  Amin A, Lin J and Wiederkehr D. Prevention of Deep-Vein Thrombosis across the Continuum Care in Patients with Congestive Heart Failure in the US. 14th Annual Scientific meeting of the Heart Failure Society of America (HFSA), 2010.

17.  Schulman KL, Johnston SS, Lin J and Huse D. Prevalence of Atrial Fibrillation (AF) in the US. 26th International Conference on Pharmacoepidemiology & Theraputic Risk Management, 2010.

18.  Deitelzweig S, Lin J, Johnson, BH and Schulman KL. Trends In The Prevalence Of Venous Thromboembolism In The United States. 21st International Thrombosis Congress, 2010. BEST POSTER AWARD.

19.  Amin A, Lin J and Wiederkehr D. Prevention Of Venous Thromboembolism In At-Risk Medical Patients In the USA. 21st International Thrombosis Congress, 2010.

20.  Amin A, Lin J and Wiederkehr D. Real-World Analysis of Venous Thromboembolism Prevention in US Patients with Ischemic Stroke. 135th Annual Meeting of the American Neurological Association, 2010.

21.  Pineo G, Lin J, Stern L, Subrahmanian T. Robust Univariate And Multivariate Sensitivity Analysis Confirm That Enoxaparin Is Costsaving To The Payers Compared With Ufh For Vte Prevention In Patients With Ischemic Stroke: Analysis Of The Prevail Data. International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 15th Annual International Meeting, 2010. 

22.  Emons MF, Lin J, Yu HT. Treatment Patterns In Atrial Fibrillation: Agents Used In Current Patient Management. International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 15th Annual International Meeting, 2010. 

23.  Emons MF, Lin J, Yu HT. Inpatient Mortality And Hospitalization Costs In Atrial Fibrillation Patients. International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 15th Annual International Meeting, 2010.

24.  Naccarelli GV, Varker H, Lin J and Schulman K. Effect of Ethnicity on Prevalence of Atrial Fibrillation Among Medicaid Patients. Heart Rhythm Society (HRS) Conference, 2010.

25.  Kim MH, Lin J, Foltz Boklage SH and Kreilick CA. Comparative Cost Of Ablation In Atrial Fibrillation Patients Stratified By Procedural Success Versus Failure: Implications For Resource Utilization In Medicare-Aged Ablation Candidates In The United States. International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 15th Annual International Meeting, 2010.  Podium Presentation.

26.  Schulman KL, Johnston SS, Lin J and Huse D. Projecting Disease Prevalence: The Impact Of Methodology– Examples In Atrial Fibrillation, International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 15th Annual International Meeting, 2010.  Workshop Panel Lead.

27.  Deitelzweig S, Lin J and Lin G. Preventing venous thromboembolism following hip replacement surgery: analysis of special populations who require alterations to anticoagulant regimens. 2010, Annual Meeting of Society of Hospital Medicine (SHM).

28.  Kim, M.H., Lin, J, Chu, BC and Schulman, KL. Total Healthcare Costs Among Atrial Fibrillation Patients in the United States in 2010. 2010 American College of Cardiology (ACC).

29.  Kim, M.H., Johnson, SS, Lin, J and Schulman, KL. Estimate of Incremental Cardiovascular Healthcare Costs in Patients with Atrial Fibrillation in the United States. 2010 American College of Cardiology (ACC).

30.  Amin A, Lin J and Ryan A. VTE Prophylaxis Across the Continuum of Care in US Orthopedic Surgery Patients. 2009 Annual Meeting of the American Society of Hematology (ASH).

31.  Deitelzweig S, Lin J, Johnson, BH and Schulman KL. Prevalence of Venous Thromboembolism Across Ethnic Groups in the United States. 2009 Annual Meeting of the American Society of Hematology (ASH).

32.  Merli GJ, Malangone E, Lin J and Stern L. Real-world VTE prophylaxis practices in US orthopedic surgery patients: an analysis of an integrated healthcare database. 2009 Annual Meeting of the American Society of Hematology (ASH).

33.  Amin A, Lin J and Ryan A. VTE Prophylaxis Across the Continuum of Care in US Medical Patients at Risk of Venous Thromboembolism. 2009 Annual Meeting of the American Society of Hematology (ASH).

34.  Deitelzweig S, Lin J, Johnson BH, Schulman KL. Current trends and future projections on the prevalence of venous thromboembolism in the USA, National Conference on Blood Disorders in Public Health, 2009. Podium Presentation.

35.  Patel PP, Johnston SS, Lin J, Schulman KL, Naccarelli GV Hospitalization And Mortality In Advanced-Age Patients With Atrial Fibrillation/Atrial Flutter But Without Heart Failure In The United States. International Society of Pharmacoeconomics and Outcomes Research - ISPOR 12th Annual European Congress, 2009

36.  Patel PP, Naccarelli GV, Johnston SS, Lin J, Schulman KL Cost Burden Of Athena Endpoints In Athena-Like Patients With Atrial Fibrillation/Atrial Flutter But Without Heart Failure In The United States.  International Society of Pharmacoeconomics and Outcomes Research - ISPOR 12th Annual European Congress, 2009

37.  Amin AN, Lin J, Johnson BH, Schulman KL Economic Outcomes in Patients at Risk of Venous Thromboembolism Receiving Best-Practice Appropriate Prophylaxis or Partial Prophylaxis, American College of Chest Physicians (ACCP) Annual Conference, 2009

38.  Amin AN, Lin J, Ryan A. VTE Prophylaxis Across the Continuum of Care in US Medical and Surgical Patients at Risk of Venous Thromboembolism. American College of Chest Physicians (ACCP) Annual Conference, 2009

39.  Amin AN and Lin J. Hospital Acquired Venous Thromboembolism Rates Following Prophylaxis with Enoxaparin and Dalteparin. American College of Chest Physicians (ACCP) Annual Conference, 2009

40.  Amin A, Lin J and, Ryan A. Analysis of inpatient and outpatient venous thromboembolism prophylaxis patterns in US critical care patients. American College of Chest Physicians (ACCP) Annual Conference, 2009. Podium Presentation.

41.  Deitelzweig S, Lin, J, Johnson BH, Schulman KL. Prevalence Of Venous Thromboembolism In The Usa: Now And Future.  XXII Congress of The International Society on Thrombosis and Haemostasis (ISTH), 2009. Podium Presentation.

42.  Pineo G, Lin, J, Stern L, Subrahmanian T. Enoxaparin Is Cost-Saving Compared With Unfractionated Heparin (Ufh) For Venous Thromboembolism Prophylaxis In Patients With Acute Ischemic Stroke: An Analysis Of Hospital Costs From The Prevail Trial.  XXII Congress of The International Society on Thrombosis and Haemostasis (ISTH), 2009

43.  Amin AN, Hussein M, Battleman D, Lin, J, Stemkowski S, Merli G. Appropriate Vte Prophylaxis, Compared With Partial Vte Prophylaxis, Leads To Lower Vte Recurrence And Cost In Us Medical Patients.  XXII Congress of The International Society on Thrombosis and Haemostasis (ISTH), 2009

44.  Pineo G, Lin, J, Stern L, Subrahmanian T. Enoxaparin For Venous Thromboembolism (VTE) Prophylaxis In Patients With Acute Ischemic Stroke Is Associated With Lower Costs To The Payers Than Unfractionated Heparin (UFH): Analysis From The Prevail Trial.  XXII Congress of The International Society on Thrombosis and Haemostasis (ISTH), 2009

45.  Amin, A., Lin, J. and Ryan A. VTE prophylaxis across the continuum of care in US cancer patients. Publication-only. American Society of Clinical Oncologists (ASCO), 2009

46.  Kim, M.H., Lin, J., Hussein, M., Kreilick, C. and Battleman D. How Much Does it Cost to Manage Atrial Fibrillation in the United States? AHA-Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Conference 2009

47.  Kim, M.H., Lin, J. and Kreilick C. A National Assessment of Medicare Prescription Coverage Gaps Among Atrial Fibrillation Patients. AHA-Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Conference 2009

48.  Patel, P.P., Gregory, C., Lin, J., Schulman, K.L. and Naccarelli, G.V. Hospitalization and Mortality in Patients With Atrial Fibrillation/Atrial Flutter and Among ATHENA-Like Patients in the United States. AHA-Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Conference 2009

49.  Patel, P.P., Johnston, S.J., Lin, J., Schulman, K.L. and Naccarelli, G.V. Cost Burden of Hospitalization and Mortality in United States Atrial Fibrillation/Flutter Patients. Heart Rhythm Society (HRS) Conference, 2009

50.  Naccarelli, G.V., Johnston, S.J., Lin, J., Patel, P.P. and Schulman, K.L. Cost Burden of ATHENA Endpoints in United States Atrial Fibrillation/Atrial Flutter Patients. Heart Rhythm Society (HRS) Conference, 2009

51.  Thosani, A.J., Xiong, Y., Lin, J., Kothawala, P. and Zimetbaum, P.J. Are Atrial Fibrillation Patients Receiving Anticoagulation in Accordance With Their Stroke Risk?  Heart Rhythm Society (HRS) Conference, 2009

52.  Amin A.N., Lin J., Johnson B., Schulman K.L. Clinical Outcomes in Patients at Risk of Venous Thromboembolism Receiving Appropriate or Partial Prophylaxis. American Thoracic Society (ATS) International Conference, 2009

53.  Kim, M.H.,  Klingman, D., Lin, J., Battleman, D. Incidence and Temporal Pattern of Hospital Readmissions for Atrial Fibrillation in Managed Care Patients Following Prior Hospitalization for this Condition. American Managed Care Pharmacy (AMCP) Annual Conference, 2009

54.  Kim M., Klingman D., Lin J., Battleman D. Patterns and predictors of discontinuation of rhythm-control therapy in patients with newly diagnosed atrial fibrillation.  American College of Cardiology (ACC), 2009

55.  Kim M., Klingman D., Lin J., Battleman D. What's the price for maintaining normal sinus rhythm? - Economics of prerequisite admission for antiarrhythmic drug initiation in atrial fibrillation. American College of Cardiology (ACC), 2009

56.  Naccarelli G.V., Varker H., Lin J., Schulman K. Increasing prevalence of atrial fibrillation and flutter in the United States: is it just due to the population aging? American College of Cardiology (ACC), 2009

57.  Ishak K.J., Proskorovsky I., Guo S., Lin J., Caro J.J. The impact of drug-related side-effects on persistence with amiodarone or sotalol in the management of atrial fibrillation: An exploratory analysis. AHA-49th Cardiovascular Disease Epidemiology and Prevention, 2009

58.  Deitelzweig S., Hussein M., Lin J., Kreilick C., Battleman D. Patterns and Predictors of Warfarin Use in Patients with Venous Thromboembolism. 2008 Annual Meeting of the American Society of Hematology (ASH).

59.  Spyropoulos A.C., Hussein M., Lin J., Battleman D. Rates of Venous Thromboembolism in Commercially Insured US Surgical Patients. 2008 Annual Meeting of the American Society of Hematology (ASH). Podium Presentation.

60.  Amin A.N., Lin J., Lenhart G., Schulman K.L. Economic Outcomes in Patients at Risk for Venous Thromboembolism Receiving Appropriate Enoxaparin or Unfractionated Heparin Prophylaxis. 2008 Annual Meeting of the American Society of Hematology (ASH).

61.  Amin A.N., Lin J., Yang G. and Stemkowski S. Clinical and Economic Outcomes Following Full or Partial ACCP Recommended Prophylaxis in Cancer Patients at Risk of Venous Thromboembolism.  2008 Annual Meeting of the American Society of Hematology (ASH). Podium Presentation.

62.  Amin, A.N., Hussein M., Battleman D., Lin J., Stemkowski S. and Merli G.J. Appropriate VTE Prophylaxis Is Associated with Lower Direct Medical Costs among Medical and Surgical Patients in the United States. 2008 Annual Meeting of the American Society of Hematology (ASH).

63.  Ishak K.J., Proskorovsky I., Guo S., Lin J., Caro J.J. Impact of non-persistence with amiodarone or sotalol on recurrence of atrial fibrillation. International Society For Pharmacoeconomics and Outcomes Research (ISPOR) European Congress 2008.

64.  Deitelzweig S., Lin J., Hussein M., Battleman D. Are surgical patients at-risk of venous thromboembolism currently meeting the surgical care improvement performance measure for appropriate and timely prophylaxis? American College of CHEST Physicians (ACCP) 2008 Meeting.

65.  Spyropoulos A.C., Hussein M., Lin J., Battleman D. Rates of venous thromboembolism occurrence in medical patients among the insured population. American College of CHEST Physicians (ACCP) 2008 Meeting.

66.  Merli G., Ferrufino C., Lin J., Hussein M., Battleman D. Total hospital-based costs of enoxaparin or fondaparinux prophylaxis in patients at risk of venous thromboembolism. American College of CHEST Physicians (ACCP) 2008 Meeting.

67.  Amin, A., Lin, J., Yang, G and Stemkowski, S. Examining the rate of appropriate, ACCP-recommended VTE prophylaxis use in heart failure patients.  September 2008, 12th Annual Scientific Meeting of Heart Failure Society of America.

68.  Merli, G., Ferrufino, C., Lin, J., Hussein, M., Battleman, D. Hospital-based Costs of Venous Thromboembolism Prophylaxis in Hospitalized Patients: a Retrospective Transactional Records Analysis, May 2008, Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, sponsored by the American Heart Association (AHA)/American Stroke Association.

69.  Amin, A., Yang, G, Lin, J. and Stemkowski, S. Rates of guideline-recommended venous thromboembolism prophylaxis in US hospital patients, April 2008, Annual Meeting of Society of Hospital Medicine (SHM).

70.  Deitelzweig S., Lin J., Becker R., Benner J.  2-year costs of enoxaparin prophylaxis, unfractionated heparin prophylaxis, or no prophylaxis in medical patients at risk of venous thromboembolism. 2008 Annual Meeting of Society of Hospital Medicine (SHM).

71.  Amin, A., Yang, G, Lin, J. and Stemkowski, S. Are hospitalized US medical patients receiving appropriate VTE prophylaxis? 2008, Annual Meeting of Society of General Internal Medincine( SGIM).

72.  Amin, A., Lin, J., Yang, G and Stemkowski, S. VTE prophylaxis use in severe lung disease patients, 2008, Annual Meeting of American Thoracic Society (ATS).

73.  Amin, A., Lin, J., Yang, G and Stemkowski, S. Rates of guideline-recommended venous thromboembolism prophylaxis in US hospital critical care patients, 2008, Annual Scientific Session of American College of Cardiology (ACC).

74.  Deitelzweig S., Becker R., Lin J., Benner J.  Comparison of the 2−Year Clinical Outcomes of VTE Prophylaxis Options in Medical Patients at Risk of VTE. 2007 Annual Meeting of the American Society of Hematology (ASH).

75.  Amin, A., Stemkowski, S., Lin, J. and Yang, G. Rates of Guideline-Recommended Venous Thromboembolism Prophylaxis in Surgical Patients Among US Hospitals: A Real-World Analysis. 2007 Annual Meeting of the American Society of Hematology (ASH).

76.  Merli, G., Ferrufino, C., Lin, J. and Hussein M. Low Molecular Weight Heparin Reduces the Cost of Venous Thromboembolism Treatment Compared with Unfractionated Heparin in US Hospitals. 2007 Annual Meeting of the American Society of Hematology (ASH).

77.  Deitelzweig S., Becker R., Lin J., Benner J.  Identifying VTE prophylaxis-related costs and outcomes, 19th Annual National Forum, Institute for Healthcare Improvement (IHI).

78.  Amin, A., Stemkowski, S.A., Lin, J., and Yang G. (June 2007) Assessing adherence to the American College of Chest Physicians’ recommendations for thromboprophylaxis in hospitalized cancer patients, American Society of Clinical Oncology (ASCO) 2007 Annual Meeting.

79.  Merli, G., Ferrufino, C., Lin, J. and Hussein M. (May 2007)  Venous Thromboembolism (VTE) Treatment With Low Molecular Weight Heparin Reduces Total Hospital Costs And VTE-Related Readmission, 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, sponsored by the American Heart Association (AHA)/American Stroke Association.

80.  Stemkowski, S.A., Lin, J., Yang G. and Amin, A. (May 2007) VTE Prophylaxis in US Hospitals, 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, sponsored by the American Heart Association (AHA)/American Stroke Association.

81.  Amin, A., Stemkowski, S.A., Lin, J., and Yang G. (April 2007) Assessing Adherence to the American College of Chest Physicians’ (ACCP) Recommendations for Thromboprophylaxis in Hospitalized Acute Medical Patients, Society of General Internal Medicine (SGIM) 30^th Annual Meeting; Podium Presentation.

82.  Ferrufino, C., Lin, J. and Hussein M. (April 2007)  Inpatient use of low molecular weight heparin (LMWH) reduces hospital-based treatment costs associated with venous thromboembolism (VTE) prophylaxis, Society of General Internal Medicine (SGIM) 30^th Annual Meeting.

83.  Amin, A., Stemkowski, S.A., Lin, J., and Yang G. (Feb. 2007) Improving Preventive Care: Assessing Adherence To The Sixth American College Of Chest Physicians’ Recommendations For Thromboprophylaxis In At-Risk Cardiovascular And Stroke Patients In Us Hospitals, American Federation for Medical Research (AFMR), 2007 Western Region Meeting.

84.  Amin, A., Stemkowski, S.A., Lin, J., and Yang G. (Feb. 2007) Improving Preventive Care: Assessing Adherence To The Sixth American College Of Chest Physicians’ Recommendations For Thromboprophylaxis In At-Risk Cardiovascular And Stroke Patients In Us Hospitals, American Federation for Medical Research (AFMR), 2007 Western Region Meeting; Podium Presentation.

85.  Spyropoulos, A. and Lin, J.  (Dec. 2006) Economic burden of venous thromboembolism from a health plan perspective across the USA, 41^st American Society of Health-system Pharmacy (ASHP) Midyear Clinical Meeting and Exhibition

86.  Amin, A., Stemkowski, S.A., Lin, J., and Yang G. (Dec. 2006) Thromboprophylaxis in US hospitals: adherence to the sixth American College of Chest Physicians’ recommendations for at-risk medical and surgical patients. 41^st American Society of Health-system Pharmacy (ASHP) Midyear Clinical Meeting and Exhibition

87.  Amin, A., Stemkowski, S.A., Lin, J., and Yang G. (Nov. 2006) Thromboprophylaxis compliance in U.S. hospitals: adherence to the sixth American College of Chest Physician’s recommendations for at-risk medical patients; American College of CHEST Physicians (ACCP) 2007  Meeting, Abstracts 2006 130: 87S-c; Podium Presentation.

88.  Spyropoulos, A. and Lin, J.  (Nov. 2006) Hospital readmission and economic burden of venous thromboembolism: from a health plan perspective; American College of CHEST Physicians (ACCP) 2007  Meeting, Abstracts 2006 130: 260S-a.

89.  Yu, H., Dylan, M.L., Lin, J., and Dubois, R.W., (May 2006) Prophylaxis of Venous Thromboemblism: Do Providers Follow Guidelines?  7th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, sponsored by the American Heart Association (AHA) /American Stroke Association.

90.  Wang M.L., Pena, R., Heine, D., Huang, L., Richardson, R., Parsons, J., Lin, J., Sykes, S., Dong, F., Zhang, Y., Hauge, B. and Laurie C. (2001) Sequence organization of homeologous regions of the soybean (Glycine Max L.) genome. Plant & Animal Genome IX

91.  Lin, J., Qi, R. Jing, J., Aston, C., White, O., and Schwartz, D.C. (1998) Optical Mapping of Whole Microbial Genomes: E. coli and Deinococcus radiodurans. Microbial & Comparative Genomics, Vol 3, No.1, 81

92.  Wang, W., Lin, J., and Schwartz, D.C. (1997) Imaging and Analyzing Straightened DNA Molecules Fixed on a Surface. Annals of Biomedical Engineering, Vol 25, S.1, 7

93.  Qi, R., Lin, J., Jing, J., Aston, C., Anantharaman, T., Mishra, B., White, O., and Schwartz, D.C. (1998) Optical Mapping of whole microbial genomes: E. coli K-12 and Deinococcus radiodurans. Genome Mapping, Sequencing & Biology, 1998, Cold Spring Harbor, 194

94.  Schwartz, D.C., Anantharaman, T., Aston, C., Mishra, B., Clarke, V., Gebauer, D., Delobette, S., Dimalanta, E., Edington, J., Evenzehav, A., Giacalone, J., Hiort, C., Huff, E., Jing, J., Lai, Z., Lee, E., Lin, J., Porter, B., et al (1998) Optical Mapping of Microbial Genomes. Microbial & Comparative Genomics, Vol 3, No.1, 56-57

95.  Schwartz, D.C., Mishra, B., Anantharaman, T., Aston, C., Cai, W., Clarke, V., Delobette, S., Dimalanta, E., Edington, J., Giacalone, J., Hiort, C., Hu, X., Huff, E., Jing, J., Lai, Z., Lee, E., Lin, J., Murti, J. et al (1997) New Single Molecule Approaches to Genomic Analysis: Optical Mapping. Microbial & Comparative Genomics, Vol 2, No.3, 179

96.  Schwartz, D.C., Mishra, B., Anantharaman, T., Aston, C., Cai, W., Clarke, V., Delobette, S., Dimalanta, E., Edington, J., Giacalone, J., Hiort, C., Hu, X., Huff, E., Jing, J., Lai, Z., Lee, E., Lin, J., Murti, J. et al (1997) New Single Molecule Approaches to Genomic Analysis: Optical Mapping.  Journal of Biomolecular Structure and Dynamics, Vol 14, No.6, 861